Science
Galip Can Uyar: Vitamin D as a Prognostic Marker in Metastatic Hormone-Sensitive Prostate Cancer
Galip Can Uyar/LinkedIn

Galip Can Uyar: Vitamin D as a Prognostic Marker in Metastatic Hormone-Sensitive Prostate Cancer

Galip Can Uyar, Medical Doctor at Etlik City Hospital, shared on X:

“Happy to share our new study published in The Oncologist!

Title: Baseline 25-Hydroxyvitamin D and Progression-Free Survival in de novo mHSPC: Prognostic Model Development and External Validation

Authors: Galip Can Uyar, Kadriye Başkurt, Orhun Akdoğan, Enes Yeşilbaş, Mustafa Ersoy, Tuba Uğur Tuzcu, Kadriye Bir Yücel, Mustafa Altınbaş, Ömür Berna Çakmak Öksüzoğlu, Gökşen İnanç İmamoğlu, Osman Sütcüoğlu

Read The Full Article

In patients with de novo mHSPC, baseline 25(OH)D provided prognostic information for progression-free survival and contributed to a prognostic model that was externally validated.”

You may also be interested in: Vitamin D and Cancer: Myths, Facts, and What Recent Evidence Shows (2021–2025)

Galip Can Uyar

 

cancer Enes Yeşilbaş Galip Can Uyar Gökşen İnanç İmamoğlu Kadriye Baskurt Kadriye Bır Yucel Mustafa Altınbaş Mustafa Ersoy Ömür Berna Çakmak Öksüzoğlu OncoDaily Oncology Orhun Akdogan Osman Sütcüoğlu prostate cancer Tuba Ugur Tuzcu vitamin D